Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Asymchem Laboratories Tianjin Co's average EPS without NRIGrowth Rate was 18.50% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -31.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 3.30% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 21.60% per year.
During the past 13 years, Asymchem Laboratories Tianjin Co's highest 3-Year average EPS without NRI Growth Rate was 80.10% per year. The lowest was -31.00% per year. And the median was 29.15% per year.
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Asymchem Laboratories Tianjin Co Earnings per Share (Diluted) Related Terms
Asymchem Laboratories Tianjin Co Earnings per Share (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co Earnings per Share (Diluted) Chart
ASLTY vs VRTX, REGN, ALNY: Earnings per Share (Diluted) Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co PE Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's PE Ratio distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's PE Ratio falls into.
Asymchem Laboratories Tianjin Co Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.22 mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Earnings per Share (Diluted) of $0.22 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Asymchem Laboratories Tianjin Co and its competitors. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #1062 out of 1168 companies in the Biotechnology industry, placing it in the top 90.9%.
Is Asymchem Laboratories Tianjin Co's Earnings per Share (Diluted) too high?
Asymchem Laboratories Tianjin Co's current Earnings per Share (Diluted) is $0.22. The Biotechnology industry median Earnings per Share (Diluted) is 16.40. Asymchem Laboratories Tianjin Co's value of $0.22 is 98.7% below this industry median. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #1062 out of 1168 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Earnings per Share (Diluted) compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #1062 out of 1168 companies for Earnings per Share (Diluted). This places Asymchem Laboratories Tianjin Co in the lower half of its industry. The industry median Earnings per Share (Diluted) is 16.40. Asymchem Laboratories Tianjin Co's value of $0.22 is 98.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Biotechnology company?
The median Earnings per Share (Diluted) among Biotechnology companies is 16.40, based on 1,168 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asymchem Laboratories Tianjin Co's current Earnings per Share (Diluted) of $0.22 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median Earnings per Share (Diluted) is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current Earnings per Share (Diluted) is $0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.63, compared to a current price of $6.37 — trading 75.5% above its estimated fair value. The current Earnings per Share (Diluted) is $0.22 and 98.7% below the Biotechnology industry median of 16.40. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Earnings per Share (Diluted) is $0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 75.5% above its estimated GF Value™ of $3.63.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Earnings per Share (Diluted): $0.22
GF Value™: $3.63 vs. price of $6.37 (75.5% above fair value)
Industry Position: 98.7% below the Biotechnology median (#1062 of 1168)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score
Get the complete analysis for ASLTY
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
